8-K
filed April 13, 2026, 7:59 PM ET
ticker PMI
CIK 0002030617
debt
confidence high
sentiment negative
materiality 0.55
Picard Medical, Inc. (PMI): debt financing — Picard Medical closes $500K convertible note with Quick Capital; 80K origination shares issued
Picard Medical, Inc.
- Issued convertible note with $555,556 principal; funded $500,000 after $55,556 OID; cash received $490,000 after expenses.
- Note bears 12% one-time interest ($66,667); matures 9 months; repayable in 6 monthly installments of $103,704 starting July 1, 2026.
- Issued 80,128 origination shares (15% of note value) as additional consideration.
- Upon default, note accelerates at 150% and convertible at 75% of lowest prior 10-day trading price, subject to 4.99% ownership limit.
- Until note is satisfied, Company cannot pay dividends or make distributions without Buyer's consent.
Key facts
Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Picard Medical, Inc. incurred convertible notes of $555,555.56 with Quick Capital, LLC at twelve percent maturing nine (9) months from the Issue Date.
- Instrument
- convertible notes
- Principal
- $555,555.56
- Counterparty
- Quick Capital, LLC
- Rate
- twelve percent
- Maturity
- nine (9) months from the Issue Date
- Event
- incurrence
Exact text from the filing
On April 7, 2026, Picard Medical, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Quick Capital, LLC, a Wyoming limited liability company (the “Buyer”), an accredited investor, for the issuance and sale of a convertible promissory note in the principal face amount of $555,555.56 (the “Note”)
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Picard Medical, Inc. issued 80,128 shares of the Company’s common stock of common stock to Quick Capital, LLC.
- Security
- common stock
- Shares
- 80,128 shares of the Company’s common stock
- Purchaser
- Quick Capital, LLC
Exact text from the filing
the issuance and sale of a convertible promissory note in the principal face amount of $555,555.56 (the “Note”) and 80,128 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), as origination shares (the “Origination Shares”).
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Picard Medical, Inc. issued principal face amount of $555,555.56 of convertible note to Quick Capital, LLC for $490,000.00.
- Security
- convertible note
- Shares
- principal face amount of $555,555.56
- Purchaser
- Quick Capital, LLC
- Consideration
- $490,000.00
Exact text from the filing
issued with an original issue discount of $55,555.56, resulting in an aggregate funded amount of $500,000.00. The cash consideration delivered to the Company at the closing was $490,000.00, after giving effect to the original issue discount and $10,000.00 withheld and directed for the Buyer’s expenses. The Note bears a one-time interest charge of twelve percent, or
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Picard Medical, Inc. entered into Purchase Agreement with Quick Capital, LLC valued at $555,555.56 (effective 2026-04-07).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Quick Capital, LLC
- Value
- $555,555.56
- Effective
- 2026-04-07
Exact text from the filing
On April 7, 2026, Picard Medical, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Quick Capital, LLC, a Wyoming limited liability company (the “Buyer”), an accredited investor, for the issuance and sale of a convertible promissory note in the principal face amount of $555,555.56
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.